highly significantP < 0.0001
The median overall survival was not reached for any group receiving [ 225 Ac]Ac-mcp-TDI-Y-010, with highly significant survival benefits observed across all dose levels ( P < 0.0001 for the 9.25- and 18.5-kBq cohorts, P = 0.0002 for the 37.0-kBq cohort) ( Figs. 2B and 2C ).